Search

Author/Creator Sleijfer, Stefan

1. 'Cost-effectiveness of the three EMA-approved adjuvant systemic therapies in patients with high-risk melanoma: a model-based economic evaluation'. Issue 2 (February 2022)

Authors:
Mulder, Evalyn; Smit, Lisanne; Grünhagen, Dirk; Verhoef, Kees; Sleijfer, Stefan; van der Veldt, Astrid; Groot, Carin Uyl-de
Journal:
European journal of surgical oncology
Issue:
Volume 48:Issue 2(2022)
Page Start:
e50
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A nationwide prospective clinical trial on active surveillance in patients with non-intra-abdominal desmoid-type fibromatosis; the Grafiti trial. Issue 2 (February 2022)

Authors:
Schut, Anne-Rose; Timbergen, Milea; van Broekhoven, Danique; van Dalen, Thijs; van Houdt, Winan; van Coevorden, Frits; Bonenkamp, Johannes; Dijkstra, Sander; Bemelmans, Marc; Been, Lukas; van Ginkel, Robert; Sleijfer, Stefan; Grünhagen, Dirk; Verhoef, Cornelis
Journal:
European journal of surgical oncology
Issue:
Volume 48:Issue 2(2022)
Page Start:
e50
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A Nationwide Prospective Clinical Trial on Active Surveillance in Patients With Non-intraabdominal Desmoid-type Fibromatosis: The GRAFITI Trial. Issue 4 (15th April 2023)

Authors:
Schut, Anne-Rose W.; Timbergen, Milea J. M.; van Broekhoven, Danique L. M.; van Dalen, Thijs; van Houdt, Winan J.; Bonenkamp, Johannes J.; Sleijfer, Stefan; Grunhagen, Dirk J.; Verhoef, Cornelis
Journal:
Annals of surgery
Issue:
Volume 277:Issue 4(2023)
Page Start:
689
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. A phase I study on the combination of neoadjuvant radiotherapy plus pazopanib in patients with locally advanced soft tissue sarcoma of the extremities. (September 2015)

Authors:
Haas, Rick L. M.; Gelderblom, Hans; Sleijfer, Stefan; van Boven, Hester H.; Scholten, Astrid; Dewit, Luc; Borst, Gerben; van der Hage, Jos; Kerst, J. Martijn; Nout, Remi A.; Hartgrink, Henk H.; de Pree, Ilse; Verhoef, Cornelis; Steeghs, Neeltje; van Coevorden, Frits
Journal:
Acta oncologica
Issue:
Volume 54:Number 8(2015)
Page Start:
1195
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. A pipeline for copy number profiling of single circulating tumour cells to assess intrapatient tumour heterogeneity. Issue 16 (8th July 2022)

Authors:
Deger, Teoman; Mendelaar, Pauline A. J.; Kraan, Jaco; Prager‐van der Smissen, Wendy J. C.; van der Vlugt‐Daane, Michelle; Bindels, Eric M. J.; Sieuwerts, Anieta M.; Sleijfer, Stefan; Wilting, Saskia M.; Hollestelle, Antoinette; Martens, John W. M.
Journal:
Molecular oncology
Issue:
Volume 16:Issue 16(2022)
Page Start:
2981
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. A randomized phase 2 study exploring the role of bevacizumab and a chemotherapy‐free approach in HER2‐positive metastatic breast cancer: The HAT study (BOOG 2008‐2003), a Dutch Breast Cancer Research Group trial. Issue 19 (17th June 2016)

Authors:
Drooger, Jan C.; van Tinteren, Harm; de Groot, Steffen M.; ten Tije, Albert J.; de Graaf, Hiltje; Portielje, Johanneke E. A.; Jager, Agnes; Honkoop, Aafke; Linn, Sabine C.; Kroep, Judith R.; Erdkamp, Frans L. G.; Hamberg, Paul; Imholz, Alex L. T.; van Rossum‐Schornagel, Quirine C.; Heijns, Joan B...
Journal:
Cancer
Issue:
Volume 122:Issue 19(2016)
Page Start:
2961
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Alternative dosing strategies for immune checkpoint inhibitors to improve cost-effectiveness: a special focus on nivolumab and pembrolizumab. Issue 12 (December 2022)

Authors:
Malmberg, Ruben; Zietse, Michiel; Dumoulin, Daphne W; Hendrikx, Jeroen J M A; Aerts, Joachim G J V; van der Veldt, Astrid A M; Koch, Birgit C P; Sleijfer, Stefan; van Leeuwen, Roelof W F
Journal:
Lancet oncology
Issue:
Volume 23:Issue 12(2022)
Page Start:
e552
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗